Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 18,556 shares at $138.26 ($2.6M) on 2021-03-15, disclosed to the SEC on 2021-03-16.
Open-market sale of $2.6M MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $136.00 | 411 | $56K | 2.1% |
| 2 | $137.00 | 801 | $110K | 4.2% |
| 3 | $138.26 | 602 | $83K | 3.2% |
| 4 | $138.26 | 602 | $83K | 3.2% |
| 5 | $139.09 | 300 | $42K | 1.6% |
| 6 | $140.38 | 1,874 |
| $263K |
| 10.1% |
| 7 | $140.38 | 1,874 | $263K | 10.1% |
| 8 | $141.31 | 2,988 | $422K | 16.1% |
| 9 | $141.31 | 2,988 | $422K | 16.1% |
| 10 | $142.17 | 2,101 | $299K | 11.4% |
| 11 | $142.17 | 2,101 | $299K | 11.4% |
| 12 | $143.09 | 957 | $137K | 5.2% |
| 13 | $143.09 | 957 | $137K | 5.2% |
| Total | $140.96 avg | 18,556 | $2.6M | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |